These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37352941)

  • 21. Vitamin D and bone.
    Suda T; Ueno Y; Fujii K; Shinki T
    J Cell Biochem; 2003 Feb; 88(2):259-66. PubMed ID: 12520524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality.
    Lieben L; Stockmans I; Moermans K; Carmeliet G
    Bone; 2013 Nov; 57(1):123-31. PubMed ID: 23895994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats.
    Yao J; Kathpalia P; Bushinsky DA; Favus MJ
    J Clin Invest; 1998 May; 101(10):2223-32. PubMed ID: 9593778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
    Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
    Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo.
    Saito H; Harada S
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():189-96. PubMed ID: 24291401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH.
    Ueno Y; Shinki T; Nagai Y; Murayama H; Fujii K; Suda T
    J Cell Biochem; 2003 Oct; 90(2):267-77. PubMed ID: 14505343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parathyroid hormone prevents 1,25 (OH)2D3 induced down-regulation of the vitamin D receptor in growth plate chondrocytes in vitro.
    Klaus G; May T; Hügel U; von Eichel B; Rodriguez J; Fernandez P; Reichrath J; Ritz E; Mehls O
    Kidney Int; 1997 Jul; 52(1):45-51. PubMed ID: 9211345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia.
    Rovito D; Belorusova AY; Chalhoub S; Rerra AI; Guiot E; Molin A; Linglart A; Rochel N; Laverny G; Metzger D
    Nat Commun; 2020 Dec; 11(1):6249. PubMed ID: 33288743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consequences of vitamin D receptor regulation for the 1,25-dihydroxyvitamin D3-induced 24-hydroxylase activity in osteoblast-like cells: initiation of the C24-oxidation pathway.
    Staal A; van den Bemd GJ; Birkenhäger JC; Pols HA; van Leeuwen JP
    Bone; 1997 Mar; 20(3):237-43. PubMed ID: 9071474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for 1,25-dihydroxyvitamin D3-independent transactivation by the vitamin D receptor: uncoupling the receptor and ligand in keratinocytes.
    Ellison TI; Eckert RL; MacDonald PN
    J Biol Chem; 2007 Apr; 282(15):10953-62. PubMed ID: 17310066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells.
    Curtis KM; Aenlle KK; Roos BA; Howard GA
    Mol Endocrinol; 2014 May; 28(5):644-58. PubMed ID: 24597546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.
    Sela-Brown A; Russell J; Koszewski NJ; Michalak M; Naveh-Many T; Silver J
    Mol Endocrinol; 1998 Aug; 12(8):1193-200. PubMed ID: 9717845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
    Tetlow LC; Woolley DE
    Arthritis Res; 1999; 1(1):63-70. PubMed ID: 11056661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
    Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
    Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism.
    St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA
    J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice.
    Boyan BD; Sylvia VL; McKinney N; Schwartz Z
    J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
    Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
    Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D in thyroid tumorigenesis and development.
    Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
    Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.